Elisa Diana Julianti
Pusat Riset Kesehatan Masyarakat dan Gizi, Badan Riset dan Inovasi Nasional

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

PENGENDALIAN OBESITAS MENURUT STATUS KOMORBID DI MASA PANDEMI COVID-19 Woro Riyadina; Elisa Diana Julianti; Prisca Petty Arfines; Nuzuliyati Nurhidayati; Irlina Raswanti Irawan; Mohamad Samsudin
Penelitian Gizi dan Makanan (The Journal of Nutrition and Food Research) Vol. 45 No. 2 (2022): PGM VOL 45 NO 2 TAHUN 2022
Publisher : Persagi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22435/pgm.v45i2.6201

Abstract

ABSTRACT The trend of obesity continues to increase consistently in Indonesia, even though the government has targeted to maintain the prevalence. Comorbidities play a role in controlling obesity, especially during the COVID-19 pandemic. This study aimed to determine the main determinants of obesity control according to comorbid status during the COVID-19 pandemic. A longitudinal study on 814 cases of obese adults aged 31 years or older who were part of the “Cohort Study of Non-Communicable Disease (NCD) Risk Factors” data in Bogor City. The sample is obese cases (Body Mass Index more or equal to 25 kg/m2) who have complete BMI data before the pandemic (2019) and during the COVID-19 pandemic (2021). The dependent variable was the change in BMI which is defined as the difference (delta) of BMI before and during the COVID-19 pandemic then categorized into three groups (stable, increased, and decreased). The main independent variable was comorbid status which was categorized as healthy, 1 NCD and ≥ 1 NCD). Covariate variables include demographic characteristics, health status (obesity, Common Mental Disorder (CMD), and risk behavior (smoking, length of sitting, exercise, dietary patterns). Data were analyzed by multinomial logistic regression at a significance of p<0.05. During the COVID-19 pandemic, obese cases who were able to control obesity (Stable BMI) at around 36.5 percent and who were able to reduce BMI was 24.6 percent. The main determinant of comorbid to stable BMI was education (OR 2.9 95% CI 1.361 – 6.070, p=0.006), while the determinant of decreased BMI was sitting time for 5.9 hours (OR 1.6 95% CI 1.122– 2.331, p=0.010) after controlling for other factors. Specific nutrition intervention strategies are needed individually, especially for obese cases with low education by considering the health status and increasing physical activity as a healthy lifestyle. Keywords: changes in BMI, control, comorbid, obese, COVID-19 pandemic ABSTRAK Tren obesitas terus meningkat secara konsisten di Indonesia, meskipun pemerintah sudah menargetkan untuk mempertahankan prevalensi obesitas. Komorbid berperan dalam pengendalian obesitas khususnya pada masa pandemi COVID-19. Tujuan studi menentukan determinan utama pengendalian obesitas menurut status komorbiditas di masa pandemi COVID-19. Sebuah studi longitudinal pada 814 kasus obese dewasa umur ≥31 tahun bagian dari data “Studi Kohor Faktor Risiko Penyakit Tidak Menular” di Kota Bogor. Sampel adalah kasus obese (IMT ≥ 25 kg/m2) yang mempunyai data IMT lengkap sebelum pandemi (2019) dan pada masa pandemi COVID-19 (2021). Variabel terikat adalah perubahan IMT yang merupakan selisih (delta) IMT sebelum dan pada masa pendemi COVID-19 dikategorikan menjadi tiga kelompok (stabil, turun dan naik). Variabel bebas utama adalah status komorbid yang dikategorikan menjadi sehat, 1 PTM dan ≥ 1 PTM. Variabel kovariat meliputi karakteristik demografi, status kesehatan (obesitas, gejala mental emosional (GME), perilaku berisiko: merokok, lama duduk, olahraga, pola konsumsi). Data dianalisis dengan regresi logistik multinomial pada signifikansi p< 0,05. Selama masa pandemi COVID-19, kasus obese yang mampu mengendalikan obesitas (IMT Stabil) 36,5 persen dan mampu menurunkan IMT sebesar 24,6 persen. Determinan utama hubungan komorbid dengan IMT stabil adalah pendidikan (OR 2,9 95% CI 1,361 – 6,070, p=0,006) sedangkan determinan utama perubahan IMT turun adalah lama duduk ≤ 5,9 jam (OR 1,6 95% CI 1,122– 2,331, p=0,010) setelah mengontrol faktor lain. Diperlukan strategi intervensi gizi yang spesifik secara individual, khususnya bagi kasus obese dengan tingkat pendidikan rendah dengan mempertimbangkan status sehat (tanpa komorbid) dan peningkatkan aktivitas fisik sebagai gaya hidup sehat. Kata kunci: perubahan IMT, kendali, komorbid, obesitas, pandemi COVID-19
EFEK KONSUMSI TAPIOKA TERMODIFIKASI EKSTRAK TEH HIJAU TERHADAP PROFIL LIPID SERUM DARAH, ENZIM SUPEROKSIDA DISMUTASE (SOD) DAN MALONALDEHID (MDA) HATI TIKUS DIABETES Elisa Diana Julianti; Nunung Nurjanah; Yunita Diana Sari
Penelitian Gizi dan Makanan (The Journal of Nutrition and Food Research) Vol. 45 No. 2 (2022): PGM VOL 45 NO 2 TAHUN 2022
Publisher : Persagi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22435/pgm.v45i2.6277

Abstract

ABSTRACT Diabetes is still a public health problem. Dyslipidemia and oxidative stress are common symptoms that accompany the disease. Green tea is a food source of antioxidants and antidyslipidemic. Starch is the main source of carbohydrates in the daily diet of people which contributes to more than half of energy intake. Tapioca starch (Manihot utilissima) could be physically and chemically modified with 4% green tea extract 58-62 oBrix as an antidiabetic functional food. This study aimed to determine the effect of tapioca starch modified with 4% green tea extract on blood lipid profiles (cholesterol, high-density lipoprotein-HDL, low-density lipoprotein-LDL, triglycerides) and liver antioxidant activity (activity of the enzyme superoxide dismutase-SOD, malonaldehyde-MDA) of diabetic rats. The Sprague Dawley rats aged two months weight of 175-250 g, were induced by streptozotocin and fed with tapioca starch modified with 4% green tea extract for 35 days. Blood lipid profile and liver antioxidant activity were analyzed by spectrophotometry. The results showed that tapioca starch modified with 4% green tea extract was not significantly reduced cholesterol, triglyceride, LDL, and MDA levels and increased HDL and SOD enzyme activity (p>0.05). The rats had an average blood lipid profile level of 9.6 – 70.8 mg/dL, SOD enzyme activity 0.561-0.885 U/mg, and malonaldehyde levels 0.025 – 0.090 nmol/mg. The study concluded that tapioca starch modified with 4% green tea extract 58-62 oBrix had not been effective yet in improving the blood lipid profile and antioxidant activity of diabetic rats. Keywords: blood lipid profiles, diabetic rats, green tea, liver antioxidant activity, modified tapioca starch ABSTRAK Penyakit Diabetes masih menjadi masalah kesehatan masyarakat. Dislipidemia dan stress oksidatif merupakan gejala umum yang menyertai penyakit tersebut. Teh hijau merupakan bahan pangan sumber antioksidan dan anti dyslipidemia. Pati adalah sumber karbohidrat utama dalam diet harian masyarakat yang menyumbangkan asupan energi lebih dari setengah kebutuhan. Pati tapioka (Manihot utilissima) dapat dimodifikasi secara fisik dan kimia dengan ekstrak teh hijau 4% dan berperan sebagai pangan fungsional antidiabetes. Penelitian ini bertujuan mengetahui efek pemberian pati tapioka termodifikasi teh hijau 4%, 58-62 oBrix terhadap profil lipid darah (kolesterol, high density lipoprotein-HDL, low density lipoprotein-LDL, trigliserida) dan aktivitas antioksidan hati (aktivitas enzim superoksida dismutase-SOD, malonaldehid-MDA) tikus diabetes. Tikus yang digunakan adalah tikus Sprague Dawley umur dua bulan dengan berat 175-250 g. Tikus diinduksi menjadi diabetes dengan streptozotocin dan diberi pakan tapioka termodifikasi ekstrak teh 4% selama 35 hari. Profil lipid darah dan aktivitas antioksidan hati dianalisis dengan spektrofotometri. Hasil menunjukkan bahwa pemberian pati tapioka termodifikasi teh hijau 4% tidak signifikan menurunkan kadar kolesterol, trigliserida, LDL dan MDA serta meningkatkan HDL dan aktivitas enzim SOD (p>0,05). Tikus percobaan memiliki rerata kadar profil lipid darah 9,6 – 70,8 mg/dL, aktivitas enzim SOD 0,561-0,885 U/mg dan kadar malonaldehid 0,025 – 0,090 nmol/mg. Penelitian ini menyimpulkan bahwa pati tapioka termodifikasi teh hijau 4%, 58-62 oBrix belum terbukti efektif memperbaiki profil lipid darah dan aktivitas antioksidan tikus diabetes. Kata kunci: aktivitas antioksidan hati, profil lipid darah, tapioka termodifikasi, teh hijau, tikus diabetes